Outcomes Associated with the Use of the Auryon Peripheral Atherectomy System in a Hospital Setting: 1-Year Outcome
Vito Gallicchio, Danilo Barbarisi, Pietro Armigliato, Federico Flora, Antonio Peluso, Rosaria Sciarrillo, Loris Flora
Background: Although endovascular approaches are the primary treatment for stenosis or occlusion of lower extremity arteries, major dissections and embolic events are the main risks. Therefore, there is a need to experiment with new technologies that not only limit these risks but also achieve the targeted clinical outcomes.
Methods: The Auryon (AngioDynamics) atherectomy system uses a 355nm wavelength laser platform that enables the use of longer wavelengths and shorter pulses to produce a groundbreaking delivery of short UV laser pulse combined with dedicated optical catheters. This study evaluated the safety and efficacy of this device in patients with Peripheral Artery Disease (PAD) treated at our hospital between October 2022 and October 2023.
Results: 12 patients were included. The mean age was 66.1 ± 9.0 years, and 83.3% of patients were male. Lesions were all below the knee. Two patients had in-stent restenosis. Chronic total occlusions and critical limb ischemia were present in 49.9% of patients, respectively. Procedural success was reached in 84% of patients. No patients had amputations. No patient experienced procedure-related complications and no patient died.
Conclusion: The Auryon laser system was shown to be safe and effective in a hospital patient population, as patients did not present any adverse events or deaths due to the procedure and in fact reported an improvement in their baseline condition.
Highlights
• Population of hospital patients with chronic total stenosis and intrastent critical occlusion.
• Procedural success was achieved in all patients.
• No patients experienced procedure-related complications.
